Multilateral Session 4A
Michael S. ShapiroSenior Counsel for Copyright, Office of Policy and External Affairs, United States Patent and Trademark Office, Alexandria
Michele WoodsDirector, Copyright Law Division, World Intellectual Property Organization, Geneva
Copyright Developments at WIPO
Antony TaubmanDirector, Intellectual Property Division, World Trade Organization, Geneva
After TPP: What Prospects for a New Round of Bilaterals?
Bhamati ViswanathanLegal Fellow, Center for the Protection of Intellectual Property (CPIP), Alexandria
The Importance of IP to Developing Countries
Prof. Jerome H. ReichmanDuke Law School, Durham
Why the Nagoya Protocol to the Convention on Biodiversity Matters to Science and Industry in the United States
Although the United States has not ratified the Convention on Biological Diversity, its scientists and industries will feel its effects now that the Nagoya Protocol has entered into force. Scientists who work with non-compliant plant cultivars or microbial specimens will find it difficult to publish research results without incurring legal and reputational consequences. Exports of industrial end-products derived from non-compliant genetic resources risk seizure as contraband in 190 member countries.